News from sumitovant biopharma A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle.

Latest

Nov 12, 2020, 17:00 ET Sumitovant Biopharma and Urovant Sciences Announce Sumitovant's Acquisition of Remaining Stake in Urovant

Sumitovant Biopharma and Urovant Sciences (Nasdaq: UROV) today announced that they have entered into a definitive merger agreement for Sumitovant to...


Jun 01, 2020, 17:11 ET Sumitovant Biopharma Announces Myovant Sciences' Submission of New Drug Application (NDA) to the FDA for Once-Daily Relugolix Combination Tablet for the Treatment of Women with Uterine Fibroids

Sumitovant Biopharma Ltd. announced today that Myovant Sciences (NYSE: MYOV), a healthcare company focused on redefining care for women and for men,...


May 29, 2020, 17:00 ET Sumitovant Biopharma Announces Myovant Sciences' Additional Positive Efficacy and Cardiovascular Safety Data from Phase 3 HERO Study of Once-Daily, Oral Relugolix in Advanced Prostate Cancer and Publication in the New England Journal of Medicine

Sumitovant Biopharma Ltd. announced that Myovant Sciences (NYSE: MYOV), a healthcare company focused on redefining care for women and for men, and...


May 21, 2020, 08:30 ET Sumitovant Biopharma's Family of Companies Achieve Multiple Clinical and Corporate Milestones in the First Full Quarter of Sumitovant's Operation

Sumitovant Biopharma, Inc. today announced that members of its family of five healthcare companies achieved multiple clinical and corporate...


Apr 29, 2020, 16:45 ET Sumitovant Biopharma Announces Publication of Myovant Abstracts Detailing Additional Efficacy and Safety Findings from Phase 3 Liberty Studies in Uterine Fibroids in Obstetrics & Gynecology

Sumitovant Biopharma Ltd. today announced that the journal Obstetrics & Gynecology has published three abstracts from Myovant Sciences detailing...


Apr 24, 2020, 10:58 ET Sumitovant Biopharma Reports Key Clinical and Regulatory Milestones by Myovant Sciences

Sumitovant Biopharma Ltd. today announced that Myovant Sciences, one of five healthcare companies in the Sumitovant family of companies, achieved...


Dec 30, 2019, 07:00 ET Sumitovant Biopharma Created and Launched as Sumitomo Dainippon Pharma and Roivant Sciences Close Transaction for Strategic Alliance

Sumitovant Biopharma Ltd. was today unveiled as a new, global biopharmaceutical company through the closing of the transaction previously announced...